Sunday, 26 June 2022

Eurofins enters clinical genetic testing market in Vietnam

10 February 2022 | News

Eurofins believes that specialised genetic testing to support critical healthcare needs is a significant growth opportunity

image credit- shutterstock

image credit- shutterstock

Eurofins Scientific has announced that its subsidiary, Eurofins Clinical Testing Lux Sarl, has acquired Genetic Testing Service JSC (Gentis), a pioneer in genetic testing in Vietnam.

The acquisition will further enhance Eurofins’ expansion in Asia and complement its global network of clinical diagnostics laboratories focused on specialised and advanced genetic testing.

Gentis is the market leader in specialised genetic testing in Vietnam and was founded on the principle that the technological advancements in DNA testing should be accessible and affordable to everyone. The company provides comprehensive specialised DNA testing services including obstetrical genetics; genealogical DNA tests; oncology; and COVID-19 testing services.

Gentis delivered revenues of around EUR 10 million in 2021. This acquisition will accelerate Eurofins’ strategy to expand its presence in South East Asia more broadly. Gentis has a highly successful test and product menu, which will benefit from the Eurofins network’s broad menu of genetic and genomic tests and its access to additional markets.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account